Ergothioneine for cognitive health, longevity and healthy ageing: where are we now?
- 19 September 2025
- journal article
- review article
- Published by Cambridge University Press (CUP) in Proceedings of the Nutrition Society
- Vol. 85 (3) , 311-325
Abstract
As the global population ages, the prevalence of cognitive decline is rising, creating urgent demand for proactive strategies that support brain health and healthy ageing. Ergothioneine, a unique dietary amino-thione absorbed via the OCTN1 transporter, has recently gained attention for its potential as a neuroprotective, longevity-promoting compound. This review synthesizes growing evidence from observational, interventional and mechanistic studies. Observational data consistently associate low blood ergothioneine levels with cognitive impairment, neurodegenerative diseases, cardiovascular disorders, frailty and mortality. Interventional trials in older adults suggest that ergothioneine supplementation may improve cognition, memory, sleep quality and stabilize neurodegeneration biomarkers, with no safety concerns at doses up to 25 mg/day. Mechanistic studies reveal that ergothioneine acts through multiple pathways: mitigating oxidative stress, reducing neuroinflammation, preserving mitochondrial function and potentially modulating neurogenesis and NAD + metabolism, although some mechanisms require further investigation. Beyond cognition, ergothioneine shows promise in supporting other physiological systems relevant to ageing, including cardiovascular, metabolic, gut, eye, auditory, liver, kidney, immune, skin and lung health. Together, current evidence positions ergothioneine as a promising nutritional intervention for promoting cognitive resilience and systemic health in ageing, although larger, long-term interventional trials are needed to confirm causality and optimize use.Keywords
This publication has 155 references indexed in Scilit:
- The Role and Molecular Pathways of SIRT6 in Senescence and Age‐related DiseasesAdvanced Biology, 2025
- Metabolomic and lipidomic signatures in autosomal dominant and late‐onset Alzheimer's disease brainsAlzheimer's & Dementia, 2022
- Does Lactobacillus reuteri influence ergothioneine levels in the human body?FEBS Letters, 2022
- Improved synthesis of an ergothioneine PET radioligand for imaging oxidative stress in Alzheimer’s diseaseFEBS Letters, 2022
- Ergothioneine in the brainFEBS Letters, 2022
- Matching chemical properties to molecular biological activities opens a new perspective on l‐ergothioneineFEBS Letters, 2021
- Inhibition of amyloid‐induced toxicity by ergothioneine in a transgenic Caenorhabditis elegansmodelFEBS Letters, 2019
- A Potential Design Flaw of Randomized Trials of Vitamin SupplementsJAMA, 2011
- Prediction of Dementia by Subjective Memory ImpairmentEffects of Severity and Temporal Association With Cognitive ImpairmentDementia and Subjective Memory ImpairmentArchives of General Psychiatry, 2010
- Mediterranean diet and risk for Alzheimer's diseaseAnnals of Neurology, 2006